SUCLG1
Basic information
Region (hg38): 2:84423528-84460045
Links
Phenotypes
GenCC
Source:
- mitochondrial DNA depletion syndrome 9 (Strong), mode of inheritance: AR
- mitochondrial DNA depletion syndrome 9 (Definitive), mode of inheritance: AR
- mitochondrial DNA depletion syndrome 9 (Supportive), mode of inheritance: AR
- Leigh syndrome (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria) | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Musculoskeletal; Neurologic | 17668387; 19526370; 20693550; 21093335; 21639866 |
ClinVar
This is a list of variants' phenotypes submitted to
- Mitochondrial DNA depletion syndrome 9 (12 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SUCLG1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 53 | 54 | ||||
missense | 100 | 110 | ||||
nonsense | 6 | |||||
start loss | 2 | |||||
frameshift | 4 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 6 | 8 | 14 | |||
non coding | 51 | 22 | 80 | |||
Total | 12 | 9 | 111 | 106 | 22 |
Highest pathogenic variant AF is 0.0000263
Variants in SUCLG1
This is a list of pathogenic ClinVar variants found in the SUCLG1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-84423539-T-C | Mitochondrial DNA depletion syndrome 9 • Mitochondrial DNA depletion syndrome | Benign/Likely benign (Jun 14, 2018) | ||
2-84423583-A-G | Mitochondrial DNA depletion syndrome 9 • Mitochondrial DNA depletion syndrome | Benign (Jun 23, 2018) | ||
2-84423620-C-T | Mitochondrial DNA depletion syndrome 9 | Uncertain significance (Jan 13, 2018) | ||
2-84423691-C-G | Mitochondrial DNA depletion syndrome • Mitochondrial DNA depletion syndrome 9 | Likely benign (Aug 17, 2018) | ||
2-84423708-G-A | Mitochondrial DNA depletion syndrome 9 • Mitochondrial DNA depletion syndrome | Uncertain significance (Jun 14, 2016) | ||
2-84423732-AT-A | Mitochondrial DNA depletion syndrome • Mitochondrial DNA depletion syndrome 9 | Uncertain significance (Jun 14, 2016) | ||
2-84423759-C-G | Mitochondrial DNA depletion syndrome • Mitochondrial DNA depletion syndrome 9 | Uncertain significance (Jun 14, 2016) | ||
2-84423761-C-G | Mitochondrial DNA depletion syndrome 9 | Uncertain significance (Jun 27, 2022) | ||
2-84423778-G-A | Mitochondrial DNA depletion syndrome 9 | Likely benign (Aug 17, 2022) | ||
2-84423786-A-C | Mitochondrial DNA depletion syndrome 9 | Likely benign (Apr 24, 2023) | ||
2-84423785-A-AAG | Mitochondrial DNA depletion syndrome 9 | Likely benign (Apr 19, 2023) | ||
2-84423790-A-T | Mitochondrial DNA depletion syndrome 9 | Likely benign (Jul 29, 2023) | ||
2-84423980-G-A | Benign (Jul 07, 2018) | |||
2-84425409-G-T | Mitochondrial DNA depletion syndrome 9 | Uncertain significance (Apr 27, 2023) | ||
2-84425419-T-C | Mitochondrial DNA depletion syndrome 9 | Uncertain significance (Jan 30, 2024) | ||
2-84425424-C-T | Mitochondrial DNA depletion syndrome 9 | Likely benign (Jan 25, 2024) | ||
2-84425425-G-A | Mitochondrial DNA depletion syndrome 9 | Uncertain significance (Feb 08, 2022) | ||
2-84425439-T-C | Mitochondrial DNA depletion syndrome 9 | Likely benign (Aug 17, 2023) | ||
2-84425441-C-CA | - | no classification for the single variant (-) | ||
2-84425456-C-T | Uncertain significance (Mar 18, 2021) | |||
2-84425460-A-G | Mitochondrial DNA depletion syndrome 9 | Likely benign (Nov 17, 2020) | ||
2-84425470-C-T | Mitochondrial DNA depletion syndrome • Mitochondrial DNA depletion syndrome 9 | Uncertain significance (Dec 22, 2023) | ||
2-84425477-G-A | Uncertain significance (Dec 18, 2012) | |||
2-84425480-C-G | Mitochondrial DNA depletion syndrome 9 | Uncertain significance (Jul 03, 2022) | ||
2-84425493-T-C | Mitochondrial DNA depletion syndrome 9 | Likely benign (Jan 21, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SUCLG1 | protein_coding | protein_coding | ENST00000393868 | 9 | 36523 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000482 | 0.971 | 125727 | 0 | 21 | 125748 | 0.0000835 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.217 | 199 | 191 | 1.04 | 0.00000980 | 2229 |
Missense in Polyphen | 73 | 79.789 | 0.91491 | 961 | ||
Synonymous | -0.132 | 72 | 70.6 | 1.02 | 0.00000384 | 708 |
Loss of Function | 1.94 | 8 | 16.5 | 0.485 | 8.11e-7 | 200 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000579 | 0.0000579 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.000115 | 0.000114 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Succinyl-CoA synthetase functions in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of either ATP or GTP and thus represents the only step of substrate-level phosphorylation in the TCA. The alpha subunit of the enzyme binds the substrates coenzyme A and phosphate, while succinate binding and specificity for either ATP or GTP is provided by different beta subunits. {ECO:0000255|HAMAP- Rule:MF_03222}.;
- Disease
- DISEASE: Mitochondrial DNA depletion syndrome 9 (MTDPS9) [MIM:245400]: A severe disorder due to mitochondrial dysfunction. It is characterized by infantile onset of hypotonia, lactic acidosis, severe psychomotor retardation, progressive neurologic deterioration, and excretion of methylmalonic acid. {ECO:0000269|PubMed:17668387, ECO:0000269|PubMed:19526370, ECO:0000269|PubMed:20453710, ECO:0000269|PubMed:20693550}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Citrate cycle (TCA cycle) - Homo sapiens (human);Propanoate metabolism - Homo sapiens (human);Valproic Acid Pathway, Pharmacodynamics;Pathway_PA165964473;Warburg Effect;The oncogenic action of Succinate;The oncogenic action of Fumarate;Pyruvate dehydrogenase deficiency (E3);Pyruvate dehydrogenase deficiency (E2);2-ketoglutarate dehydrogenase complex deficiency;Mitochondrial complex II deficiency;Fumarase deficiency;Congenital lactic acidosis;Citric Acid Cycle;Glutaminolysis and Cancer;The oncogenic action of 2-hydroxyglutarate;The oncogenic action of L-2-hydroxyglutarate in Hydroxygluaricaciduria;The oncogenic action of D-2-hydroxyglutarate in Hydroxygluaricaciduria ;Amino Acid metabolism;TCA Cycle;Citrate cycle;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;TCA cycle;TCA cycle;superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle
(Consensus)
Recessive Scores
- pRec
- 0.535
Intolerance Scores
- loftool
- 0.235
- rvis_EVS
- -0.47
- rvis_percentile_EVS
- 23.25
Haploinsufficiency Scores
- pHI
- 0.163
- hipred
- N
- hipred_score
- 0.376
- ghis
- 0.557
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.987
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Suclg1
- Phenotype
Gene ontology
- Biological process
- tricarboxylic acid cycle;succinyl-CoA metabolic process;succinate metabolic process;nucleoside diphosphate phosphorylation;nucleoside triphosphate biosynthetic process
- Cellular component
- mitochondrion;mitochondrial matrix;cytosol;plasma membrane
- Molecular function
- RNA binding;nucleoside diphosphate kinase activity;succinate-CoA ligase (ADP-forming) activity;cofactor binding